更正：基于肝细胞癌坏死性凋亡相关基因的预后标志物的构建与验证
Correction: Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
作者信息
Peng Yue-Ling, Wang Ling-Xiao, Li Mu-Ye, Liu Li-Ping, Li Rong-Shan
出版信息
PLoS One. 2025 Sep 5;20(9):e0331773. doi: 10.1371/journal.pone.0331773. eCollection 2025.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0279744.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0279744。]
相似文献
1
Correction: Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.更正：基于肝细胞癌坏死性凋亡相关基因的预后标志物的构建与验证
PLoS One. 2025 Sep 5;20(9):e0331773. doi: 10.1371/journal.pone.0331773. eCollection 2025.
2
Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.基于肝细胞癌中坏死性凋亡相关基因构建和验证预后签名。
PLoS One. 2023 Feb 16;18(2):e0279744. doi: 10.1371/journal.pone.0279744. eCollection 2023.
3
Correction: Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma.更正：用于预测肝细胞癌预后和治疗反应的m7G相关长链非编码RNA特征的鉴定与验证
PLoS One. 2025 Sep 5;20(9):e0331772. doi: 10.1371/journal.pone.0331772. eCollection 2025.
4
Construction and immunohistochemical validation of a necroptosis-related prognostic signature in bladder cancer and its association with tumor immune infiltration.膀胱癌中坏死性凋亡相关预后标志物的构建、免疫组化验证及其与肿瘤免疫浸润的关联
Front Genet. 2025 Aug 14;16:1527907. doi: 10.3389/fgene.2025.1527907. eCollection 2025.
5
Identification of necroptosis-related long non-coding RNAs prognostic signature and the crucial lncRNA in bladder cancer.膀胱癌中坏死性凋亡相关长链非编码RNA预后特征及关键长链非编码RNA的鉴定
J Cancer Res Clin Oncol. 2023 Sep;149(12):10217-10234. doi: 10.1007/s00432-023-04886-w. Epub 2023 Jun 3.
6
A comprehensive analysis of the potential role of necroptosis in hepatocellular carcinoma using single-cell RNA Seq and bulk RNA Seq.使用单细胞RNA测序和批量RNA测序对坏死性凋亡在肝细胞癌中的潜在作用进行综合分析。
J Cancer Res Clin Oncol. 2023 Nov;149(15):13841-13853. doi: 10.1007/s00432-023-05208-w. Epub 2023 Aug 3.
7
Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma by integrated analysis of single-cell and bulk RNA sequencing.通过单细胞和批量RNA测序的综合分析，鉴定并验证基于肝细胞特异性基因的肝细胞癌新型预测特征
BMC Med Genomics. 2024 Apr 23;17(1):103. doi: 10.1186/s12920-024-01871-1.
8
Construction of a prognostic model for lung adenocarcinoma based on necroptosis genes and its exploration of the potential for tumor immunotherapy.基于坏死性凋亡基因构建肺腺癌预后模型及其肿瘤免疫治疗潜力探索
Transl Cancer Res. 2025 May 30;14(5):2563-2579. doi: 10.21037/tcr-24-2165. Epub 2025 May 26.
9
Construction and validation of a necroptosis-related lncRNA signature for predicting the prognosis of gastrointestinal cancer patients.用于预测胃肠道癌患者预后的坏死性凋亡相关长链非编码RNA特征的构建与验证
Front Immunol. 2025 Aug 14;16:1591252. doi: 10.3389/fimmu.2025.1591252. eCollection 2025.
10
Comprehensive bioinformatics analysis of a RBM family-based prognostic signature with experiment validation in hepatocellular carcinoma.基于 RBM 家族的预后特征的综合生物信息学分析，并在肝细胞癌中进行实验验证。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11891-11905. doi: 10.1007/s00432-023-05084-4. Epub 2023 Jul 6.
本文引用的文献
1
Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.基于肝细胞癌中坏死性凋亡相关基因构建和验证预后签名。
PLoS One. 2023 Feb 16;18(2):e0279744. doi: 10.1371/journal.pone.0279744. eCollection 2023.
Zotero 插件